NEXIEN BIOPHARMA, INC. Quarterly Return On Assets in % from Q2 2017 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Nexien Biopharma, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2017 to Q3 2024.
  • Nexien Biopharma, Inc. Return On Assets for the quarter ending September 30, 2024 was -3.02K %, a 342% decline year-over-year.
  • Nexien Biopharma, Inc. annual Return On Assets for 2024 was -2.22K %, a 334% decline from 2023.
  • Nexien Biopharma, Inc. annual Return On Assets for 2023 was -511 %, a 43.1% increase from 2022.
  • Nexien Biopharma, Inc. annual Return On Assets for 2022 was -898 %, a 84.3% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -3.02K -2.33K -342% Jul 1, 2024 Sep 30, 2024
Q2 2024 -2.22K -1.71K -334% Apr 1, 2024 Jun 30, 2024
Q1 2024 -1.2K -799 -199% Jan 1, 2024 Mar 31, 2024
Q4 2023 -866 -446 -106% Oct 1, 2023 Dec 31, 2023
Q3 2023 -683 -45.7 -7.17% Jul 1, 2023 Sep 30, 2023
Q2 2023 -511 +387 +43.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -401 +1.18K +74.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -420 +1.38K +76.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -637 +2.41K +79.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -898 +4.81K +84.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -1.58K +5.79K +78.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 -1.8K +4.12K +69.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -3.05K +887 +22.5% Jul 1, 2021 Sep 30, 2021
Q2 2021 -5.7K -3.53K -163% Apr 1, 2021 Jun 30, 2021
Q1 2021 -7.37K -5.8K -370% Jan 1, 2021 Mar 31, 2021
Q4 2020 -5.91K -5.07K -604% Oct 1, 2020 Dec 31, 2020
Q3 2020 -3.94K -3.14K -394% Jul 1, 2020 Sep 30, 2020
Q2 2020 -2.17K -1.59K -272% Apr 1, 2020 Jun 30, 2020
Q1 2020 -1.57K -1.21K -337% Jan 1, 2020 Mar 31, 2020
Q4 2019 -840 -538 -178% Oct 1, 2019 Dec 31, 2019
Q3 2019 -797 -657 -469% Jul 1, 2019 Sep 30, 2019
Q2 2019 -583 -442 -313% Apr 1, 2019 Jun 30, 2019
Q1 2019 -358 -203 -131% Jan 1, 2019 Mar 31, 2019
Q4 2018 -303 -94.5 -45.4% Oct 1, 2018 Dec 31, 2018
Q3 2018 -140 +229 +62.1% Jul 1, 2018 Sep 30, 2018
Q2 2018 -141 -1.74 -1.25% Apr 1, 2018 Jun 30, 2018
Q1 2018 -155 Jan 1, 2018 Mar 31, 2018
Q4 2017 -208 Oct 1, 2017 Dec 31, 2017
Q3 2017 -369 Jul 1, 2017 Sep 30, 2017
Q2 2017 -140 Mar 27, 2017 Jun 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.